FINWIRES · TerminalLIVE
FINWIRES

$ACAD

3 stories mentioning ACADUpdated just now

Every FINWIRES story that references ACAD, newest first.

Sectors

Sector Update: Healthcare Stocks Gain Friday Afternoon

Healthcare stocks were higher Friday afternoon, with the NYSE Healthcare Index rising 2.3% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 2.5%.The iShares Biotechnology ETF (IBB) climbed 1.5%.In corporate news, Johnson & Johnson (JNJ) shares gained 3.5% after the company said Friday that a European Medicines Agency committee recommended expanding Tecvayli's approval in combination with daratumumab for adults with relapsed or refractory multiple myeloma who have received at least one prior therapy.Cumberland Pharmaceuticals (CPIX) shares jumped past 7% after the company presented updated phase 2 results showing additional evidence that ifetroban may help protect heart function in patients with Duchenne muscular dystrophy.Acadia Pharmaceuticals (ACAD) shares climbed nearly 9% after it said the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion of Daybu following a re-examination procedure, recommending approval of the drug to treat neurobehavioral symptoms of Rett syndrome in patients aged five and older.

$ACAD$CPIX$JNJ
Sectors

Sector Update: Healthcare Stocks Mixed Premarket Friday

Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) marginally higher and the iShares Biotechnology ETF (IBB) down 0.1%.ACADIA Pharmaceuticals (ACAD) stock was up nearly 10% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion of Daybu following a re-examination procedure, recommending approval of the drug to treat neurobehavioral symptoms of Rett syndrome in patients aged five and older.Incyte (INCY) shares were up 1.8% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of Opzelura cream for adults with moderate atopic dermatitis.Avalo Therapeutics (AVTX) will be added to the small-cap Russell 2000 index and the broad-market Russell 3000 index, effective after market close Friday. Shares of Avalo Therapeutics were up more than 1% pre-bell.

$ACAD$AVTX$IBB$INCY$XLV
Sectors

Sector Update: Healthcare

Healthcare stocks were narrowly mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) marginally higher and the iShares Biotechnology ETF (IBB) down 0.1%.Acadia Pharmaceuticals (ACAD) was up more than 13% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use adopted a positive opinion of Daybu following a re-examination procedure, recommending approval of the drug to treat neurobehavioral symptoms of Rett syndrome in patients aged five and older.

$ACAD

Track with the FINWIRES app suite